Clinical stage pharmaceutical company Cantex Pharmaceuticals has obtained a global licence from Harvard University’s Office of Technology Development to develop the small-molecule drug ...

WESTON, Fla., Dec. 9, 2024 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life ...

The drug is being researched as a treatment for multiple forms of cancer. Cantex received orphan drug designation for Azeliragon from the FDA. Azeliragon targets brain metastasis from breast ...